D. E. Shaw & Co., Inc. - GAMIDA CELL LTD ownership

GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 60 filers reported holding GAMIDA CELL LTD in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of GAMIDA CELL LTD
ValueSharesWeighting
Q2 2023$241,289
+1233.5%
125,020
+459.6%
0.00%
Q1 2023$18,095
-43.5%
22,340
+9.6%
0.00%
Q3 2022$32,000
-80.2%
20,391
-77.7%
0.00%
Q2 2022$162,000
-72.3%
91,521
-35.0%
0.00%
-100.0%
Q1 2022$585,000
-9.2%
140,846
-44.5%
0.00%0.0%
Q4 2021$644,000
-62.3%
253,775
-41.7%
0.00%
-50.0%
Q3 2021$1,707,000
+90.9%
435,368
+212.2%
0.00%
+100.0%
Q2 2021$894,000139,4400.00%
Other shareholders
GAMIDA CELL LTD shareholders Q1 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 187$107,000,0001.12%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 175,000$307,0000.28%
Rock Springs Capital Management LP 2,175,000$3,850,0000.11%
Platform Technology Partners 57,625$102,0000.06%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,197,875$2,120,0000.05%
Guild Investment Management, Inc. 18,000$28,0000.04%
MEITAV INVESTMENT HOUSE LTD 429,352$760,0000.01%
1492 Capital Management LLC 10,000$18,0000.01%
ARK Investment Management 714,534$1,558,0000.01%
FEDERATED HERMES, INC. 1,868,896$3,308,0000.01%
View complete list of GAMIDA CELL LTD shareholders